In the rapidly evolving landscape of healthcare, precision medicine stands out as a transformative approach, customizing treatments to match individual patient profiles based on genetics, lifestyle, and environmental factors, thereby revolutionizing patient care. At the forefront of this revolution
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with extensive experience in research and development, and a deep understanding of technological innovation in the industry. Today, we’re diving into the groundbreaking work on novel monoclonal antibodies for mpox, a viral disease that
Picture a cutting-edge laboratory where robots operate tirelessly around the clock, autonomously conducting thousands of experiments to create materials that power the future of technology, all without a single human hand at the helm. This is no longer a vision of science fiction but a reality
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence conditions—diabetes, heart disease, and oncology. But a quieter revolution is unfolding in the rare disease space, where smaller patient populations are redefining how value is created. Behind every
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’re diving into the heartbreaking case of Leticia Paul, a young lawyer who
Imagine a crime scene where a single drop of blood holds the key to identifying a suspect, not just by DNA but by estimating their age with remarkable precision, a technique that has become invaluable in modern investigations. Forensic age estimation tools, relying on DNA methylation patterns, have
Drug discovery has long been a daunting endeavor, with the staggering statistic that developing a single new drug can cost upwards of $1 billion and take over a decade to reach the market. Imagine a world where this timeline is slashed, costs are dramatically reduced, and even smaller research
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the recent European Commission approval of Cabometyx for advanced
In an era where technology and biology are increasingly intertwined, imagine a world where the painstaking process of optimizing cell culture media—a cornerstone of biopharmaceutical and regenerative medicine research—is revolutionized by artificial intelligence. Machine learning, once confined to
Imagine a world where the simple act of lifting a spoon to eat or brushing one’s hair becomes an insurmountable challenge due to mobility impairments caused by conditions like amyotrophic lateral sclerosis (ALS) or stroke. For millions globally, this is a daily reality, but a groundbreaking
ITCurated uses cookies to personalize your experience on our website. By continuing to use this site, you agree to our Cookie Policy